Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
This ingredient offers free radical scavenging, detoxification, immunity enhancement, anti-cancer, and anti-radiation hazards benefits
Secondary endpoints: GSH concentrations in maternal and arterial and venous umbilical cord blood erythrocytes (by stratification based on treatment or degree of IPTB severity) and safety of antenatal NAC supplementation for mothers and infants Considering stratification for IPTB severity, median glutathione concentration in venous cord blood was similar in severe (median: 430 mol/L) and moderate (median: 402 mol/L) IPTB in the NAC arm ( P 1.0), whereas it was lower, however not significantly ( P 0.67), in severe (median: 391 mol/L) than moderate (median: 522 mol/L) IPTB group in the placebo arm (Supplemental Table S3)
PubMed laboratory research record [PMID: 1949496] PubMed record related to this compound for laboratory literature review
PMID 40789979
Target two-hour after-meal (postprandial) glucose levels For people with diabetes whose A1C levels are not at goal despite fasting glucose levels being within the targeted range (80 130 mg/dL), the ADA suggests assessment of two-hour after-meal (postprandial) glucose levels, with a targeted level of less than 180 mg/dL (ADA 2021a)
Physiol Plant 100(2):234240
